表紙
市場調査レポート

世界の左心耳 (LAA) 閉鎖市場:2016〜2020年

Global Left Atrial Appendage (LAA) Closure Market 2016-2020

発行 TechNavio (Infiniti Research Ltd.) 商品コード 346668
出版日 ページ情報 英文 57 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
世界の左心耳 (LAA) 閉鎖市場:2016〜2020年 Global Left Atrial Appendage (LAA) Closure Market 2016-2020
出版日: 2015年12月09日 ページ情報: 英文 57 Pages
概要

左心耳 (LAA) 閉鎖装置は脳卒中を予防し、心房細動による二次的脳卒中や塞栓のリスクを低減するための介入装置です。世界の左心耳閉鎖市場は2020年にかけCAGR28%で拡大するとみられています。

当レポートでは、世界の左心耳 (LAA) 閉鎖市場について調査し、市場の規模と2019年までの成長見通し、市場動向と課題、主要ベンダー、地域別動向などをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 市場調査方法

第4章 イントロダクション

第5章 市況

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第6章 パイプライン分析

第7章 法規制

第8章 製品別市場セグメンテーション

第9章 地域別分析

  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第10章 市場促進因子

  • 脳卒中の発症率上昇
  • 左心耳閉鎖装置の長期的な費用対効果
  • 高齢化

第11章 促進因子の影響

第12章 市場の課題

  • 複雑な処置
  • 装置承認のための複雑な法規制と製品リコール
  • warfarinおよびdabigatranの高い許容率

第13章 促進因子と課題の影響

第14章 市場動向

  • 治験動向
  • 認識プログラムの増加
  • 米国における大きな成長

第15章 ベンダー環境

  • 競合シナリオ
  • 2014年の市場シェア分析
  • 他の注目すべきベンダー

第16章 主要ベンダー分析

  • AtriCure
  • Boston Scientific
  • St. Jude
  • Coherex Medical

第17章 付録

第18章 Technavioについて

図表

目次
Product Code: IRTNTR7702

Market outlook of the left atrial appendage closure market

The left atrial appendage (LAA) is a small ear-shaped sac in the muscle wall of the top left chamber of the heart that controls the electrical impulses during atrial fibrillation. LAA closure device is an interventional device used to prevent stroke, reduce the risk of secondary stroke and emboli because of atrial fibrillation. The global left atrial appendage closure market is expected to grow at a massive CAGR of over 28% during the forecast period.

Numerous factors drive the left atrial appendage closure market, but one of the main factors is the significant increase in the incidences of stroke. It is estimated that around 15 million people suffer a stroke every year across the globe. With the rise in the aging population, excessive smoking, average hypertension, and cholesterol levels, the number of atrial fibrillation cases is also increasing globally.

Segmentation by product and analysis of - epicardial LAA closure and endocardial LAA closure

The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -

  • Epicardial LAA closure device
  • Endocardial LAA closure device

Endocardial involves implantation of a device to occlude the LAA. Endocardial LAA closure devices are implanted through a transseptal approach under TEE technique. A specific delivery system has been developed for each device type allowing for repositioning, collapse, or removal in the event of suboptimal results.

Geographical segmentation and analysis of - Americas, APAC, EMEA

The EMEA region is the highest revenue generator in the left atrial appendage closure market in 2015, accounting for about 52% share, and then followed by the APAC region. The market in the EMEA is expected to continue its growth during the forecast period and this is attributed to increase in the incidence of strokes and the growing elderly population. Stroke alone accounts for 1.1 million deaths in Europe every year.

The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -

  • Americas
  • APAC
  • EMEA

Competitive landscape and key vendors - AtriCure, Boston Scientific, St. Jude, Coherex Medical

The LAA closure market witness the presence of very few market vendors, hence the competition in the market is moderate at present. However, the competition is expected to intensify with new product launches. Also, there is a vast opportunity for the market to grow significantly in the Americas in the forecast period.

Primary vendors in this market are:

  • AtriCure
  • Boston Scientific
  • St. Jude
  • Coherex Medical

Other prominent vendors included in this report are Lifetech Scientific, SentreHEART, and Occlutech.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2019?
  • What are the key factors driving the global left atrial appendage closure market?
  • What are the key market trends impacting the growth of the global left atrial appendage closure market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global left atrial appendage closure market?
  • What are the market opportunities and threats faced by the vendors in the global left atrial appendage closure market?
  • What are the trending factors influencing the market shares of the APAC, EMEA, and the Americas?
  • What are the key outcomes of the five forces analysis of the global left atrial appendage closure market?
  • Technavio also offers customization on reports based on specific client requirement.

Technavio also offers customization on reports based on specific client requirement.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Pipeline analysis

PART 07: Regulation of LAA closure devices

PART 08: Market segmentation by product

PART 09: Geographical segmentation

  • Left atrial appendage closure market in Americas
  • Left atrial appendage closure market in EMEA
  • Left atrial appendage closure market in APAC

PART 10: Market drivers

  • Increasing incidences of stroke
  • Potential long-term cost-effectiveness of LAA closure devices
  • Rise in aging population

PART 11: Impact of drivers

PART 12: Market challenges

  • Complicated LAA closure implantation procedure
  • Stringent regulation for approval of device and product recalls
  • High acceptance of warfarin and dabigatran

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Focus on clinical trials
  • Increase in awareness programs
  • Significant growth in US

PART 15: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 16: Key vendor analysis

  • AtriCure
  • Boston Scientific
  • St. Jude
  • Coherex Medical

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global left atrial appendage closure market 2015-2020 ($ millions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Pipeline analysis snapshot of LAA closure device
  • Exhibit 05: Snapshot for regulation of medical devices
  • Exhibit 06: Timeline of key events - Watchman device regulations
  • Exhibit 07: Segmentation of LAA closure by product
  • Exhibit 08: Segmentation of global left atrial appendage closure market by geography 2015
  • Exhibit 09: Segmentation of global left atrial appendage closure market by geography 2020
  • Exhibit 10: Segmentation of global left atrial appendage closure market by geography 2015-2020
  • Exhibit 11: Left atrial appendage closure market in Americas 2015-2020 ($ millions)
  • Exhibit 12: Left atrial appendage closure market in EMEA 2015-2020 ($ millions)
  • Exhibit 13: Left atrial appendage closure market in APAC 2015-2020 ($ millions)
  • Exhibit 14: Impact of drivers
  • Exhibit 15: Impact of drivers and challenges
  • Exhibit 16: Key takeaways: Boston Scientific
  • Exhibit 17: Key takeaways: St. Jude Medical
  • Exhibit 18: Key takeaways: AtriCure
  • Exhibit 19: Key takeaways: Coherex Medical
  • Exhibit 20: AtriCure: Product categories
  • Exhibit 21: AtriCure: Geographical segmentation by revenue 2014
  • Exhibit 22: Boston Scientific: Business segmentation by revenue 2014
  • Exhibit 23: Boston Scientific: Business segmentation by revenue 2013 and 2014
  • Exhibit 24: St. Jude: Product segmentation by revenue 2014
  • Exhibit 25: St. Jude: Product segmentation by revenue 2013 and 2014
  • Exhibit 26: Coherex Medical: Product offering
Back to Top